As of 2026-10-13, the EV/EBITDA ratio of Clearpoint Neuro Inc (CLPT) is -11.55. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CLPT's latest enterprise value is 326.77 mil USD. CLPT's TTM EBITDA according to its financial statements is -28.28 mil USD. Dividing these 2 quantities gives us the above CLPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 16.9x | 15.2x |
| Forward P/E multiples | 17.5x - 19.8x | 18.4x |
| Fair Price | (17.16) - (16.65) | (16.56) |
| Upside | -268.2% - -263.3% | -262.4% |
| Date | EV/EBITDA |
| 2026-10-09 | -11.85 |
| 2026-10-08 | -11.86 |
| 2026-10-07 | -12.04 |
| 2026-10-06 | -12.41 |
| 2026-10-05 | -12.95 |
| 2026-10-02 | -12.29 |
| 2026-10-01 | -12.88 |
| 2026-09-30 | -13.69 |
| 2026-09-29 | -13.22 |
| 2026-09-28 | -16.97 |
| 2026-09-25 | -16.46 |
| 2026-09-24 | -16.23 |
| 2026-09-23 | -16.61 |
| 2026-09-22 | -17.48 |
| 2026-09-21 | -15.55 |
| 2026-09-18 | -15.40 |
| 2026-09-17 | -15.31 |
| 2026-09-16 | -14.95 |
| 2026-09-15 | -14.68 |
| 2026-09-14 | -15.01 |
| 2026-09-11 | -15.29 |
| 2026-09-10 | -15.03 |
| 2026-09-09 | -15.46 |
| 2026-09-08 | -15.64 |
| 2026-09-04 | -15.54 |
| 2026-09-03 | -15.64 |
| 2026-09-02 | -15.91 |
| 2026-09-01 | -16.54 |
| 2026-08-31 | -16.79 |
| 2026-08-28 | -17.23 |
| 2026-08-27 | -17.64 |
| 2026-08-26 | -18.10 |
| 2026-08-25 | -18.72 |
| 2026-08-24 | -16.82 |
| 2026-08-21 | -17.06 |
| 2026-08-20 | -16.85 |
| 2026-08-19 | -17.66 |
| 2026-08-18 | -16.83 |
| 2026-08-17 | -17.17 |
| 2026-08-14 | -17.00 |
| 2026-08-13 | -17.09 |
| 2026-08-12 | -16.83 |
| 2026-08-11 | -16.54 |
| 2026-08-10 | -16.19 |
| 2026-08-07 | -15.81 |
| 2026-08-06 | -14.94 |
| 2026-08-05 | -14.69 |
| 2026-08-04 | -14.39 |
| 2026-08-03 | -17.05 |
| 2026-07-31 | -16.58 |